|
|||||
|
|

Telecom software provider Amdocs (NASDAQ:DOX) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by 8.4% year on year to $1.14 billion. The company expects next quarter’s revenue to be around $1.15 billion, close to analysts’ estimates. Its non-GAAP profit of $1.72 per share was 0.6% above analysts’ consensus estimates.
Is now the time to buy DOX? Find out in our full research report (it’s free).
Amdocs saw a positive market response to its Q2 results, as the company delivered revenue and non-GAAP earnings per share slightly above Wall Street expectations despite an 8.4% drop in year-on-year sales. Management attributed the quarter’s performance to ongoing growth in cloud-related projects, highlighted by new modernization deals in Europe and North America, and strong execution in managed services. CEO Joshua Sheffer credited efficiency improvements and increased adoption of the company’s digital platforms for supporting profitability during a period of industry transition, stating, “Profitability improved by 10 basis points sequentially driven by internal efficiency improvements.”
Looking ahead, Amdocs’ guidance is supported by expectations for continued double-digit growth in cloud solutions and the emerging impact of generative AI deployments. Management believes that expanding commercial partnerships, particularly in generative AI and SaaS offerings, will drive incremental revenue and margin improvement. CFO Tamar Rapaport-Dagim noted, however, that the pace of AI-related revenue contribution remains uncertain, explaining, “We are starting to see conversion of proof-of-concept into commercial deals now... the pace is hard to predict.” The company is also closely monitoring macroeconomic and geopolitical factors that could influence customer spending and project timing.
Management pointed to sales momentum in cloud, the ramp-up of generative AI projects, and improved operational efficiency as key contributors to the quarter’s outcome.
Amdocs’ outlook centers on sustained cloud growth, the scaling of generative AI solutions, and prudent cost management amid industry uncertainty.
Looking forward, our analysts will track (1) the rate at which cloud migration and generative AI projects transition from pilot to commercial scale, (2) the momentum of new SaaS product launches and their adoption among telecom operators, and (3) the stability of managed services renewals and expansions. Any acceleration in AI-driven deal flow or resolution of macroeconomic uncertainties could meaningfully shape Amdocs’ growth trajectory.
Amdocs currently trades at $89.55, up from $84.60 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-27 | |
| Oct-24 | |
| Oct-23 | |
| Oct-23 | |
| Oct-23 | |
| Oct-16 | |
| Oct-15 | |
| Oct-09 | |
| Oct-08 | |
| Oct-07 | |
| Oct-02 | |
| Sep-29 | |
| Sep-28 | |
| Sep-18 | |
| Sep-10 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite